Mixed reality application MS Teams using in 3 scenarios

Mixed reality application MS Teams using in 3 scenarios - AR-Teams

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00032270

Enrollment

Registered

2023-07-20

Start date

2023-12-04

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C25 K35 K56 K80

Interventions

Group 1: The Remote Assist application allows discussion or collaboration in teams with a shared view of a patient-specific case. A post-market follow-up (PMCF) observation will confirm the safety as

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients in the Department of General and Visceral Surgery with treatment under one of the three observation scenarios Consent to participate in the study Capacity to consent

Exclusion criteria

Exclusion criteria: Refusal to participate in the study

Design outcomes

Primary

Measure	Time frame
The Remote Assist application enables discussion or collaboration in teams with a shared view of a patient-specific case. A post-market follow-up (PMCF) observation will confirm the safety as well as an acceptable benefit/risk ratio of the tool in different scenarios. Instead of the telephone or other means of communication, remote assist via VSI HoloMedicine® of the MS Team tool will be used in three different scenarios. The following scenarios are evaluated: Adding to the operating room (Whipple) (n=3), indication discussion with colleagues (n=3), and emergency support (ileus, cholelithiasis, appendicitis). The aim is long-term post-marketing clinical follow-up (PMCF) of the performance, clinical utility, and safety of the product with respect to MS Teams use of VSI HoloMedicine®.	—

Measure

Time frame

The Remote Assist application enables discussion or collaboration in teams with a shared view of a patient-specific case. A post-market follow-up (PMCF) observation will confirm the safety as well as an acceptable benefit/risk ratio of the tool in different scenarios. Instead of the telephone or other means of communication, remote assist via VSI HoloMedicine® of the MS Team tool will be used in three different scenarios. The following scenarios are evaluated: Adding to the operating room (Whipple) (n=3), indication discussion with colleagues (n=3), and emergency support (ileus, cholelithiasis, appendicitis). The aim is long-term post-marketing clinical follow-up (PMCF) of the performance, clinical utility, and safety of the product with respect to MS Teams use of VSI HoloMedicine®.

—

Secondary

Measure	Time frame
The purpose of this qualitative study is to evaluate the teams use of VSI HoloMedicine®, in the context of surgery, physician on-call, and the emergency department for the following purposes. Evaluate: Confirm the performance of the teams integration of VSI HoloMedicine® (remote assist / 3D hologram / streaming / voice quality). Deployment in different scenarios (OR / emergency / on-call) in terms of remote collaboration. Evaluation of usability, advantages and disadvantages Confirmation of the safety of the medical device Satisfaction of the users Observation of any unforeseen risks related to the function, Ensuring continued acceptance of the risk-benefit ratio. Measurement of mental workload (NASA-TLX).	—

Measure

Time frame

The purpose of this qualitative study is to evaluate the teams use of VSI HoloMedicine®, in the context of surgery, physician on-call, and the emergency department for the following purposes. Evaluate: Confirm the performance of the teams integration of VSI HoloMedicine® (remote assist / 3D hologram / streaming / voice quality). Deployment in different scenarios (OR / emergency / on-call) in terms of remote collaboration. Evaluation of usability, advantages and disadvantages Confirmation of the safety of the medical device Satisfaction of the users Observation of any unforeseen risks related to the function, Ensuring continued acceptance of the risk-benefit ratio. Measurement of mental workload (NASA-TLX).

—

Countries

Germany

Contacts

Public ContactDirk Weyhe

PIUS-Hospital Oldenburg

dirk.weyhe@pius-hospital.de+494412291472

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026